Literature DB >> 17435747

Isolation of engineered, full-length antibodies from libraries expressed in Escherichia coli.

Yariv Mazor1, Thomas Van Blarcom, Robert Mabry, Brent L Iverson, George Georgiou.   

Abstract

We describe facile isolation of full-length IgG antibodies from combinatorial libraries expressed in E. coli. Full-length heavy and light chains are secreted into the periplasm, where they assemble into aglycosylated IgGs that are captured by an Fc-binding protein that is tethered to the inner membrane. After permeabilizing the outer membrane, spheroplast clones expressing so-called E-clonal antibodies, which specifically recognize fluorescently labeled antigen, are selected using flow cytometry. Screening of a library constructed from an immunized animal yielded several antibodies with nanomolar affinities toward the protective antigen of Bacillus anthracis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17435747     DOI: 10.1038/nbt1296

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  59 in total

1.  Fluorescent IgG fusion proteins made in E. coli.

Authors:  Yael Luria; Dina Raichlin; Itai Benhar
Journal:  MAbs       Date:  2012-04-26       Impact factor: 5.857

Review 2.  Development of anti-infectives using phage display: biological agents against bacteria, viruses, and parasites.

Authors:  Johnny X Huang; Sharon L Bishop-Hurley; Matthew A Cooper
Journal:  Antimicrob Agents Chemother       Date:  2012-06-04       Impact factor: 5.191

Review 3.  Cell culture processes for monoclonal antibody production.

Authors:  Feng Li; Natarajan Vijayasankaran; Amy Yijuan Shen; Robert Kiss; Ashraf Amanullah
Journal:  MAbs       Date:  2010-09-01       Impact factor: 5.857

4.  Aglycosylated immunoglobulin G1 variants productively engage activating Fc receptors.

Authors:  Stephen L Sazinsky; René G Ott; Nathaniel W Silver; Bruce Tidor; Jeffrey V Ravetch; K Dane Wittrup
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-12       Impact factor: 11.205

5.  Bispecific antibodies with natural architecture produced by co-culture of bacteria expressing two distinct half-antibodies.

Authors:  Christoph Spiess; Mark Merchant; Arthur Huang; Zhong Zheng; Nai-Ying Yang; Jing Peng; Diego Ellerman; Whitney Shatz; Dorothea Reilly; Daniel G Yansura; Justin M Scheer
Journal:  Nat Biotechnol       Date:  2013-07-07       Impact factor: 54.908

6.  Comparing CDRH3 diversity captured from secondary lymphoid organs for the generation of recombinant human antibodies.

Authors:  Sophie Venet; Marie Kosco-Vilbois; Nicolas Fischer
Journal:  MAbs       Date:  2013-07-02       Impact factor: 5.857

7.  Engineering antibody fragments to fold in the absence of disulfide bonds.

Authors:  Min Jeong Seo; Ki Jun Jeong; Clinton E Leysath; Andrew D Ellington; Brent L Iverson; George Georgiou
Journal:  Protein Sci       Date:  2009-02       Impact factor: 6.725

8.  Isolation of human monoclonal antibodies by mammalian cell display.

Authors:  Roger R Beerli; Monika Bauer; Regula B Buser; Myriam Gwerder; Simone Muntwiler; Patrik Maurer; Philippe Saudan; Martin F Bachmann
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-23       Impact factor: 11.205

9.  Aglycosylated IgG variants expressed in bacteria that selectively bind FcgammaRI potentiate tumor cell killing by monocyte-dendritic cells.

Authors:  Sang Taek Jung; Sai T Reddy; Tae Hyun Kang; M Jack Borrok; Inger Sandlie; Philip W Tucker; George Georgiou
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-18       Impact factor: 11.205

10.  Synthetic antibody libraries focused towards peptide ligands.

Authors:  Christian W Cobaugh; Juan C Almagro; Mark Pogson; Brent Iverson; George Georgiou
Journal:  J Mol Biol       Date:  2008-03-04       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.